Cited 45 time in
Modelling neurodegenerative diseases with3Dbrain organoids
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Chang, Yujung | - |
| dc.contributor.author | Kim, Junyeop | - |
| dc.contributor.author | Park, Hanseul | - |
| dc.contributor.author | Choi, Hwan | - |
| dc.contributor.author | Kim, Jongpil | - |
| dc.date.accessioned | 2023-04-27T21:40:44Z | - |
| dc.date.available | 2023-04-27T21:40:44Z | - |
| dc.date.issued | 2020-10 | - |
| dc.identifier.issn | 1464-7931 | - |
| dc.identifier.issn | 1469-185X | - |
| dc.identifier.uri | https://scholarworks.dongguk.edu/handle/sw.dongguk/6090 | - |
| dc.description.abstract | Neurodegenerative diseases are incurable and debilitating conditions characterized by the deterioration of brain function. Most brain disease models rely on humanpost-mortembrain tissue, non-human primate tissue, orin vitrotwo-dimensional (2D) experiments. Resource limitations and the complexity of the human brain are some of the reasons that make suitable human neurodegenerative disease models inaccessible. However, recently developed three-dimensional (3D) brain organoids derived from pluripotent stem cells (PSCs), including embryonic stem cells and induced PSCs, may provide suitable models for the study of the pathological features of neurodegenerative diseases. In this review, we provide an overview of existing 3D brain organoid models and discuss recent advances in organoid technology that have increased our understanding of brain development. Moreover, we explain how 3D organoid models recapitulate aspects of specific neurodegenerative diseases, including Alzheimer's disease, Parkinson's disease, amyotrophic lateral sclerosis, and Huntington's disease, and explore the utility of these models, for therapeutic applications. | - |
| dc.format.extent | 13 | - |
| dc.language | 영어 | - |
| dc.language.iso | ENG | - |
| dc.publisher | WILEY | - |
| dc.title | Modelling neurodegenerative diseases with3Dbrain organoids | - |
| dc.type | Article | - |
| dc.publisher.location | 미국 | - |
| dc.identifier.doi | 10.1111/brv.12626 | - |
| dc.identifier.scopusid | 2-s2.0-85087207862 | - |
| dc.identifier.wosid | 000541647000001 | - |
| dc.identifier.bibliographicCitation | BIOLOGICAL REVIEWS, v.95, no.5, pp 1497 - 1509 | - |
| dc.citation.title | BIOLOGICAL REVIEWS | - |
| dc.citation.volume | 95 | - |
| dc.citation.number | 5 | - |
| dc.citation.startPage | 1497 | - |
| dc.citation.endPage | 1509 | - |
| dc.type.docType | Article | - |
| dc.description.isOpenAccess | N | - |
| dc.description.journalRegisteredClass | scie | - |
| dc.description.journalRegisteredClass | scopus | - |
| dc.relation.journalResearchArea | Life Sciences & Biomedicine - Other Topics | - |
| dc.relation.journalWebOfScienceCategory | Biology | - |
| dc.subject.keywordPlus | SPINAL MUSCULAR-ATROPHY | - |
| dc.subject.keywordPlus | AMYOTROPHIC-LATERAL-SCLEROSIS | - |
| dc.subject.keywordPlus | PLURIPOTENT STEM-CELLS | - |
| dc.subject.keywordPlus | HUMAN BRAIN-DEVELOPMENT | - |
| dc.subject.keywordPlus | ALZHEIMERS-DISEASE | - |
| dc.subject.keywordPlus | HUNTINGTONS-DISEASE | - |
| dc.subject.keywordPlus | PARKINSONS-DISEASE | - |
| dc.subject.keywordPlus | SELF-ORGANIZATION | - |
| dc.subject.keywordPlus | EARLY-ONSET | - |
| dc.subject.keywordPlus | PROTEIN | - |
| dc.subject.keywordAuthor | organoid | - |
| dc.subject.keywordAuthor | neurodegenerative disease | - |
| dc.subject.keywordAuthor | pluripotent stem cell | - |
| dc.subject.keywordAuthor | disease modelling | - |
| dc.subject.keywordAuthor | Alzheimer's disease | - |
| dc.subject.keywordAuthor | Parkinson's disease | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
30, Pildong-ro 1-gil, Jung-gu, Seoul, 04620, Republic of Korea+82-2-2260-3114
Copyright(c) 2023 DONGGUK UNIVERSITY. ALL RIGHTS RESERVED.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.
